Premium Information is available for this item - Upgrade for $1 a day
6505-01-517-1139
Bimatoprost Ophthalmic Solution
6505015171139 015171139 LUMIGAN 0.03 MG/ML LUMIGAN 0.3 MG/ML 3 FL/3ML 1684315
January 2023
4
Marketplace 6505-01-517-1139
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-517-1139 5+ Documents (More...)
Bimatoprost Ophthalmic Solution 015171139 6505-01-517-1139 6505015171139 015171139 BIMATOPROST
Bimatoprost Ophthalmic Solution 015171139 1010-12-168-4315 1010121684315 121684315 MITNEHMER https
Restrictions 6505-01-517-1139
6505-01-517-1139 is a Bimatoprost Ophthalmic Solution that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
End Users 6505-01-517-1139
- Belgium (ZB01)
- Effective Date:
- 7 Apr 2011
- Turkey (ZW01)
- Effective Date:
- 1 Jan 2004
Approved Sources 6505-01-517-1139
- Part Number
- Manufacturer
- Status
- LUMIGAN 0.03 MG/ML
- Manufacturer
- 24172 - Allergan Inc (Active)
- Primary Buy
- Primary Buy
- LUMIGAN 0.3 MG/ML 3 FL/3ML
- B7001 - Allergan (Active)
- Secondary Buy
- Secondary Buy
- 1684315
- B6095 - Association Pharmaceutique (Active)
- Canceled/Obsolete
- Canceled/Obsolete
Datasheet 6505-01-517-1139
- Characteristic
- Specifications
- FIIG
- Specifications
- A23900
- Special Features [FEAT]
- Does Not Require Refrigeration; Available In 2.5 Ml And 5 Ml Sizes; Has Been Reported To Cause Changes To Pigmented Tissues; Including Increased Pigmentation And Growth Of Eyelashes And Increased Pigmentation Of The Iris And Periorbital Tissue, Eyelid, Changes May Be Permanent
- Functional Description [FTLD]
- Is Indicated For The Reduction Of Elevated Intraocular Pressure, Iop, In Patients With Open-Angle Glaucoma Or Ocular Hypertension Who Are Intolerant Of Other Iop-Lowering Medications Or Insufficiently Responsive To Another Iop Lowering Medication; Provides Powerful Iop Reduction That Remains Consistent Over Time, Both In Number Of Patients Achieving Low Target Pressure And Overall Percentage Reduction
- Part Name Assigned By Controlling Agency [CXCY]
- Lumigan, Bimatoprost Ophthalmic Solution, 0.03 Pct
NATO Stock Numbers Related to 6505-01-517-1139
Freight Information 6505-01-517-1139
6505-01-517-1139 has freight characteristics managed by Turkey.. 6505-01-517-1139 has a variance between NMFC and UFC when transported by rail and the description should be consulted.